groove

Penn Center for AIDS Research

David H. Henry

faculty photo
Clinical Professor of Medicine
Director, AIDS Malignancy Program, University of Pennsylvania Cancer Center, Philadelphia, PA
Vice Chairman, Department of Medicine, Pennsylvania Hospital, Philadelphia, PA
Associate Program Director, Department of Medicine, Pennsylvania Hospital, Philadelphia, PA
Education Officer, Department of Medicine, Pennsylvania Hospital
Penn Medicine Clinician, Pennsylvania Hospital
Department: Medicine

Contact information
Penn Hematology/Oncology
Abramson Cancer Center
Pennsylvania Hospital, Farm Journal Building
230 West Washington Square
Philadelphia, PA 19106
Office: 215-829-6088
Fax: 215-829-6104
Education:
B.A.
Princeton University, 1970.
M.D.
University of Pennsylvania School of Medicine, 1975.
Post-Graduate Training
Intern in Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1975-1976.
Resident in Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1976-1978.
Fellowship, Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1978-1981.
Chief Medical Resident, Hospital of the University of Pennsylvania, Philadelphia, PA, 1979-1980.
Certifications
American Board of Internal Medicine, 1978.
American Board of Internal Medicine-Hematology, 1980.
American Board of Internal Medicine-Medical Oncology, 1981.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Henry DH: Quantitative Nodal Burden and Mortality across Solid Cancers. PracticeUpdate April 2022.

Henry, DH., Maki RG: Lenalidomide and the expanding toolkit to manage Kaposi sarcoma. Clin Cancer Res April 2022.

Jacobson, D., Cadieux, B., Higano, CS., Henry, DH., Bachmann, BA., Rehn, M., Stopeck, AT., Saad, H: Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach. Journal of Bone Oncology 2022.

Henry D, Barfejani AH, Prasad S: A commentary on: 2021 Top Story in Oncology: Surgically Preventing HPV-Related Anal Cancer in HIV-Infected Individuals. PracticeUpdate December 2021.

Henry,D: A commentary on: Cemiplimab With Platinum Doublet Chemo as First-Line for Advanced NSCLC. PracticeUpdate website. PracticeUpdate October 2021.

Henry D: A commentary on: Nivolumab Plus Ipilimumab vs Chemotherapy in Unresectable Mesothelioma. PracticeUpdate October 2021.

Henry D: A commentary on: Poziotinib in Treatment-Naïve NSCLC With HER2 Exon 20 Mutations. PracticeUpdate October 2021.

Henry D: A commentary on: Trastuzumab Deruxtecan for HER2-Mutated Metastatic NSCLC. PracticeUpdate October 2021.

Henry D: A commentary on: PD-L1b Inhibitors for Nsq-NSCLC. PracticeUpdate October 2021.

Schenfeld J, Henry D, Bennett C, DeCosta L, Kelsh M, Jaramillo R, Gawade P: Prophylactic G-CSF and Risk of Neutropenia-Related Hospitalization Among Metastatic and Non-Metastatic Breast Cancer Patients MASCC/ISOO Annual Meeting June 2021 Notes: POSTER PRESENTATION.

back to top
Last updated: 04/21/2022
The Trustees of the University of Pennsylvania